SCHEMBL29566388

SCHEMBL29566388

CC(C)c1ccccc1-c1cc(Oc2ccccc2F)nc(NS(=O)(=O)c2cccc(OC(F)F)c2)n1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.42
▸ SCN9A Q15858 9/20 0.41
▸ CYP2C9 P11712 1/20 0.37
▸ FBP1 P09467 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ BRD4 O60885 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ DRD2 P14416 1/20 0.34
▸ ADRA1D P25100 1/20 0.34
▸ ADRA1A P35348 1/20 0.34
▸ ADRA1B P35368 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ HTR1A P08908 1/20 0.34
▸ HTR7 P34969 1/20 0.34
▸ PLA2G7 Q13093 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310230 1.00 TDP1 (0.42) TDP1SCN9ACYP2C9FBP1LMNA
SCHEMBL24310082 0.91 ALPL (0.42) TDP1SCN9ALMNAHTTALDH1A1
SCHEMBL29566627 0.91 ALPL (0.42) TDP1SCN9ALMNAHTTALDH1A1
SCHEMBL29567008 0.88 TDP1 (0.45) TDP1SCN9ALMNAHTTBRD4
SCHEMBL24309354 0.88 TDP1 (0.45) TDP1SCN9ALMNAHTTBRD4
SCHEMBL24310800 0.88 TDP1 (0.42) TDP1SCN9ALMNAHTTBRD4
SCHEMBL29567109 0.88 TDP1 (0.42) TDP1SCN9ALMNAHTTBRD4
SCHEMBL24310091 0.87 TDP1 (0.41) TDP1SCN9ALMNAHTTBRD4
SCHEMBL29566464 0.87 KDM1A (0.45) TDP1LMNAHTTDRD2HTR1A
SCHEMBL29567206 0.87 TDP1 (0.41) TDP1SCN9ALMNAHTTBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback